tiprankstipranks
Aadi Bioscience (AADI)
NASDAQ:AADI
Holding AADI?
Track your performance easily

Aadi Bioscience (AADI) Income Statement

470 Followers

Aadi Bioscience Income Statement

Last quarter (Q3 2024), Aadi Bioscience's total revenue was $7.21M, an increase of 21.03% from the same quarter last year. In Q3, Aadi Bioscience's net income was $-12.55M. See Aadi Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 25.07M$ 24.35M$ 15.22M$ 1.12M$ 14.58M
Cost of Revenue
$ 3.16M$ 2.81M$ 1.33M$ -578.00K$ 734.00K
Gross Profit
$ 21.91M$ 21.55M$ 13.88M$ 1.00M$ 14.58M
Operating Expense
$ 85.49M$ 93.48M$ 72.84M$ 38.18M$ 17.13M
Operating Income
$ -66.22M$ -71.93M$ -62.68M$ -111.22M$ -2.55M
Net Non Operating Interest Income Expense
$ 4.63M$ 6.17M$ 2.17M$ -652.00K$ -774.00K
Other Income Expense
$ -3.70M$ -1.00K$ -3.72M$ 72.38M$ 153.00K
Pretax Income
$ -61.59M$ -65.77M$ -60.51M$ -110.09M$ -3.48M
Tax Provision
---$ 2.00K$ 2.00K
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -61.63M$ -65.77M$ -60.51M$ -110.74M$ -4.46M
Basic EPS
$ -2.28$ -2.44$ -2.69--
Diluted EPS
$ -2.28$ -2.44$ -2.69$ -12.41$ -1.50
Basic Average Shares
$ 108.02M$ 26.92M$ 22.51M$ 8.92M$ 2.84M
Diluted Average Shares
$ 108.02M$ 26.92M$ 22.51M$ 8.92M$ 2.84M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 88.66M$ 96.29M$ 74.17M$ 111.76M$ 17.86M
Net Income From Continuing And Discontinued Operation
$ -61.69M$ -65.77M$ -60.51M$ -110.09M$ -3.48M
Normalized Income
$ -40.68M$ -51.95M---
Interest Expense
-----
EBIT
$ -61.57M$ -65.53M$ -60.28M$ -109.42M$ -2.66M
EBITDA
$ -61.01M$ -65.36M$ -60.12M$ -109.32M$ -2.65M
Currency in USD

Aadi Bioscience Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis